Muscadine Plus (MPX) In Men With Prostate Cancer
Stopped The study was terminated by DSMB due to futility.
Conditions
- Adenocarcinoma of the Prostate
Interventions
- DRUG: Muscadine Plus
- DRUG: Placebos
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators